BioSpace News Archive

Business

Starbucks CMO Matthew Ryan joins Boards of Directors for Kaiser Foundation Health Plan, Inc. and Hospitals

Experienced marketing leader brings deep commitment to enhancing customer focus to Kaiser Permanente boards

January 14, 2020
·
2 min read
Deals

Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares - Jan. 14, 2020 - Jan. 14, 2020

Mirati Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 3,538,462 shares of its common stock at a public offering price of $97.50 per share.

January 14, 2020
·
3 min read
Biotech Bay

EDISON GROUP UNVEILS STELLAR SPEAKER LINE UP AT SAN FRANCISCO INVESTOR PANEL DURING THE ANNUAL HEALTHCARE WEEK

Panel speakers include life sciences investment experts from Civilization Ventures, Amgen Ventures, Canaan Partners, BEDB and Samsara BioCapital

January 14, 2020
·
2 min read
Domain Therapeutics secures €6 million ($6.7M) debt financing

GPCR company will expand proprietary portfolio and prepare next financing round

January 14, 2020
·
2 min read
FDA

CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer

The BTD filing is based on data from the first patient in the Company’s mTNBC Phase 1b/2 trial and an additional single-patient trial under an emergency investigational new drug protocol evaluating leronlimab for the treatment of HER2+ metastatic, stage 4, breast cancer

January 14, 2020
·
12 min read
Cardax, Inc. Announces Reverse Stock Split of Common Stock

Cardax expects that upon the opening of trading on January 15, 2020, its common stock will trade on the OTCQB on a split-adjusted basis under the current symbol “CDXI” and the new CUSIP number 14141D201.

January 14, 2020
·
4 min read
Deals

American Healthcare Capital Exclusively Advises Clinical Specialty Infusions (CSI) Pharmacy in Their Merger With a Market Leader in Home Health, Palliative Care, and Hospice

American Healthcare Capital, a national healthcare M&A advisory firm, is pleased to announce the merger of CSI Pharmacy and a market leader in Home Health, Palliative Care, and Hospice.

January 14, 2020
·
2 min read
Policy

Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol

Nektar Therapeutics issued a statement following a meeting of the Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee to discuss the New Drug Application for oxycodegol where the Committees did not recommend approval of oxycodegol.

January 14, 2020
·
3 min read
Deals

Heska Corporation to Acquire scil animal care, a European Leader in Veterinary Point-of-Care Diagnostics

Heska Corporation, a provider of advanced veterinary diagnostic and specialty products, announced that the Company has entered into an agreement to acquire 100% of the capital stock of scil animal care company GmbH from Covetrus, Inc.

January 14, 2020
·
8 min read
Business

Pre-close trading update confirms 2019 trading in-line with expectations

Vectura will report its preliminary results for the year ended 31 December 2019 on Tuesday 17th March 2020.

January 14, 2020
·
5 min read